BDX
BECTON DICKINSON & CO
NYSE · Healthcare · Medical - Instruments & Supplies · US
$180.94
−0.24%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $4.06
- Revenue estimate
- $5.1B
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $3.23
- EPS estimate
- $3.14
- Revenue actual
- $5.0B
- Revenue estimate
- $4.9B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +4.0%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $186
- PT range
- $170 – $204
- Analysts
- 8
3 Buy5 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $3.14 | $3.23 | Beat 2.87% | $5.0B |
| May 7, 2026 | $2.78 | $2.90 | Beat 4.32% | $4.7B |
| Nov 6, 2025 | $3.93 | $3.96 | Beat 0.84% | $5.9B |
| Aug 7, 2025 | $3.41 | $3.68 | Beat 7.82% | $5.5B |
| May 1, 2025 | $3.29 | $3.35 | Beat 1.89% | $5.3B |
| Feb 5, 2025 | $3.00 | $3.43 | Beat 14.41% | $5.2B |
| Nov 7, 2024 | $3.77 | $3.81 | Beat 1.06% | $5.4B |
| Aug 1, 2024 | $3.31 | $3.50 | Beat 5.80% | $5.0B |
| May 2, 2024 | $2.97 | $3.17 | Beat 6.73% | $5.0B |
| Feb 1, 2024 | $2.41 | $2.68 | Beat 11.11% | $4.7B |
| Nov 9, 2023 | $3.40 | $3.42 | Beat 0.47% | $5.1B |
| Aug 3, 2023 | $2.88 | $2.96 | Beat 2.74% | $4.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026